Concepedia

Beata Zamlynny

BZ

Statistics

Publications

13

Citations

744

H-Index

12

Active since

2007

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Quantitative BioSciences

University of Southern California

United States Military Academy

Beata Zamlynny is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

2007–2023

13

Publications

13

Structural basis for selectivity and diversity in angiotensin II receptors

Haitao Zhang, Gye Won Han, A. Batyuk et al. · Nature · 2017 · 212 citations · Full text

, , +9

Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation

Chuan Hong, Noel Byrne, Beata Zamlynny et al. · Nature Communications · 2021 · 116 citations · Full text

Disparity in IL-12 Release in Dendritic Cells and Macrophages in Response to <i>Mycobacterium tuberculosis</i> Is Due to Use of Distinct TLRs

Luca Pompei, Sihyug Jang, Beata Zamlynny et al. · The Journal of Immunology · 2007 · 103 citations · Full text

, , +25

Discovery of Vibegron: A Potent and Selective β<sub>3</sub>Adrenergic Receptor Agonist for the Treatment of Overactive Bladder

Scott D. Edmondson, Cheng Zhu, Nam Fung Kar et al. · Journal of Medicinal Chemistry · 2015 · 101 citations · Full text

Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive Bladder

Jerry Di Salvo, Hiroshi Nagabukuro, L. Alexandra Wickham et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 58 citations

1–5 of 13